Moxisylyte
- TRADE NAMES: Erecnos; Icavex; Opilon (Concord)
- INDICATIONS: Impotence, primary Raynaud's phenomenon
- SYNONYM: Thymoxamine (British Approved Name)
- CLASS: Alpha-adrenergic channel blocker
- HALF-LIFE: 1–2 hours
CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acebutolol, Alfuzosin, Captopril, Cilazapril, Enalapril, Fosinopril, Indoramin, Irbesartan, Lisinopril, Olmesartan, Quinapril, Ramipril, Trandolapril, Tricyclic antidepressants
Please login to see the rest of this drug profile
MUCOSAL.
CARDIOVASCULAR.
CENTRAL NERVOUS SYSTEM.
GASTROINTESTINAL/HEPATIC.
LOCAL.
OCULAR.
RESPIRATORY.
Page last updated 07/31/2023
Symbol key
Incidence
- <1%
- 1-5%
- 5-10%
- 10-15%
- 15-20%
- 20-30%
- >30%
Warnings in other populations
- Breast feeding
- Geriatric
- Pediatric